Changes in HDL cholesterol and in the inflammatory markers of atherogenesis after an oral fat load in type-2 diabetic patients and normal individuals

Metabolic Syndrome and Related Disorders

Volumn 6, Issue 2, 2008, Pages 153-157

  Coutinho, Eponina R ^a,d   Macedo, Geísa M ^b   Campos, Florisbela S ^a   Bandeira, Francisco A ^c  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Hospital Agamenon Magalhaes   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^d NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENESIS; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LEUKOCYTE COUNT; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; DIETARY FATS; FEMALE; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LEUKOCYTES; MALE; MIDDLE AGED; OBESITY; POSTPRANDIAL PERIOD;

EID: 44449177787     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2007.0032     Document Type: Article

References (30)

1. Dodson PM, Barnett AH. Lipids, Diabetes and Vascular Disease, 2nd edn. London: Science Press, 1998:57.
2. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979;60:473-85.
3. Lima JG, Nóbrega LHC, Nóbrega MLC, Bandeira F, Souza AGP. Dislipidemia pósprandial como achado precoce em indivíduos com baixo risco cardiovascular. Arq Bras Endoc e Metab 2002;46:249-254.
4. Parks EJ. Achados Recentes no Estudo da Lipemia Pós-prandial. Cur Atheros Rep Bras 2002;1:27-35.
5. Goldberg IJ. Diabetic Dyslipidemia: Causes and Consequences. The J Clin Endoc and Metab 2001;86:965-971.
6. De Man FH, Cabezas MC, van Barlingen HH, Erkelens D W, De Bruin TW. Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: postprandial metabolism and relation to premature atherosclerosis. Eur J Clin Invest 1996;26:89-108.
7. Patsch JR, Meisenbock G, Hopferweiser T, Muhlberger V, Knapp E, Dunn JK. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992;12:1336-1345.
8. Mohanlal N, Holman RR. A standardized triglyceride and carbohydrate challenge. Diabetes Care 2004;27:89-94.
9. Eriksson JW, Burén J, Svensson M, Olivecrona G. Postprandial regulation of blood lipids and adipose tissue lipoprotein lipase in type 2 diabetes patients and healthy control subjects. Atherosclerosis 2003;166:359-367.
10. Howard BV. Insulin resistance and lipid metabolism. Am J Cardiol 1999;84:28j-32j.
11. Evans M, Khan N, Rees A. Diabetic dyslipidaemia and coronary heart disease: new perspectives. Current Opinion in Lipidology 1999;10:387-391.
12. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-126.
13. Kreisberg RA, Oberman, A. Lipids and atherosclerosis: lessons learned from randomized controlled trials of lipid lowering and other relevant studies. J Clin Endoc Metab 2002;87:423-437.
14. Cabezas MC, Sijmonsma TP, Meijssen S, Erkelens DW, van Dijk H. Postprandial recruitment of leukocytes: part of the inflammatory process of atherosclerosis? Atherosclerosis Suppl 2001;2:37.
15. Pradhan AD, Manson JE, Rifai N, Buring J, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-334.
16. King ED, Mainous III AG, Pearson WS. C-reactive protein, diabetes, and attendance at religious services. Diabetes Care 2002;25:1172-1176.
17. Davi G, Falco A, Patrono C. Determinants of F2-isoprostane biosynthesis and inhibition in man. Chem Phys Lipids Mar 2004;128:149-163.
18. van Oostrom AJ, Rabelink TJ, Verseyden C, Sijmonsma TP, Plokker HW, De Jaegere PP. Activation of leukocytes by postprandial lipemia in healthy volunteers. Atherosclerosis 2004;177:175-82.
19. van Oostrom AJ, Sijmonsma TP, Verseyden C, Jansen EH, De Koning EJ, Rabelink TJ. M. Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J Lipid Res Mar 2003;44:576-583.
20. van Oostrom AJ, Sijmonsma TP, Rabelink TJ, van Asbeck BS, Cabezas MC. Postprandial leukocyte increase in healthy subjects. Metabolism 2003;52:199-202.
21. Friedewald WT, Levy R, Fredrickson DS. Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
22. Price CP. Development and validation of a particle.enhanced turbidimetric immunoassay for C.reactive protein. J Immunol Methods 1987;99:205-211.
23. Altman DG. Practical Statistics for Medical Research. Great Britain, London: Chapman and Hall, 1991:611.
24. Zar JH. Biostatistical Analysis, 4th ed. USA, New Jersey: Prentice Hall, 1999:929.
25. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care 1997;20:1683-1687.
26. Kane JP. Disorders of Lipoprotein Metabolism. In Greenspan FS ed. Basic and Clinical Endocrinology, 5nd edn. London, 1997:680-709.
27. Bansal S, Buring JE, Rifai N. Fasting Compared with Nonfasting Triglycerides and Risk of Cardiovascular Events in Women. JAMA 2007;298:309-316.
28. Nordestgaard BG, Benn M, Schnohr P et al. Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women. JAMA 2007;298:299-308.
29. de Ugarte MT, Portal VL, Dias AA, Schaan BD. Metabolic response to oral lipid overload in diabetes and impaired glucose tolerance. Diabetes Res Clin Pract 2005;69:36-43.
30. Signori LU, Plentz RDM, Irigoyen MC, Schaan BD. O papel da lipemia pós.prandial na gênese da aterosclerose: particularidades do diabetes mellitus. Arq Bras Endoc e Metab 2007;51:222-231.